Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Giant Cell Arteritis: early-phase trial registry
5 of 8 indexed Giant Cell Arteritis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 5 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Giant Cell Arteritis: 8 US clinical trials tracked, 5 recruiting.
Giant Cell Arteritis is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Pennsylvania, running 4 of these trials.
Enrollment posture brief
Registry condition giant-cell-arteritis
OPEN 5 | RECR 63% | LATE 1 | EARLY 2 | RANK #2176 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Adolescent (63% recruiting · 16 trials)
Giant Cell Arteritis lists 5 open slots (63% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Giant Cell Arteritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Giant Cell Arteritis is recruiting above its size-band peers.
5 of 8 indexed trials (62.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Giant Cell Arteritis research.
University of Pennsylvania accounts for 4 of 8 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Giant Cell Arteritis enrolment sits around 707 participants.
Median target enrolment is 707 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.
-
Giant Cell Arteritis research leans observational.
3 interventional and 5 observational studies make up this index (37.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT02257866
One-Time DNA Study for Vasculitis
University of Pennsylvania
NCT01241305
VCRC Tissue Repository
University of Pennsylvania
NCT02967068
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
University of Pennsylvania
NCT05865054
Abatacept for the Treatment of Giant Cell Arteritis
University of Pennsylvania
NCT04474847
Vasculitis Illness Perception (VIP) Study
University of South Florida
NCT02190916
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT00556439
KPL-301 for Subjects With Giant Cell Arteritis
Kiniksa Pharmaceuticals
NCT03827018
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Giant Cell Arteritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Giant Cell Arteritis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Giant Cell Arteritis page
8 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Giant Cell Arteritis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Pennsylvania sponsors the most Giant Cell Arteritis trials on record, review their full trial history before evaluating a specific study. See University of Pennsylvania's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Giant Cell Arteritis condition card totals 8 registered trials; most-linked intervention Abatacept; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.